skip to main content

Chemistry, part 1

زبان محتوا

پشتیبانی: CRM@email.irandoc.ac.ir

Concept information

organooxygen compound > carbohydrates and carbohydrate derivatives > carbohydrate derivative > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > carboxamide > peptide > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid
organooxygen compound > carboxamide > peptide > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > amide > primary amide > carboxamide > peptide > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > carbon group molecular entity > organic molecular entity > organic amino compound > peptide > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid
... > chemical entity > molecular entity > main group molecular entity > p-block molecular entity > pnictogen molecular entity > nitrogen molecular entity > organonitrogen compound > organic amino compound > peptide > glycopeptide > (2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid

اصطلاح مرجح

(2s,5r,10r,13r)-16-/{[(2r,3s,4r,5r)-3-/{[(2s,3r,4r,5s,6r)-3-acetamido-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy/}-5-(ethylamino)-6-hydroxy-2-(hydroxymethyl)oxan-4-yl]oxy/}-5-(4-aminobutyl)-10-carbamoyl-2,13-dimethyl-4,7,12,15-tetraoxo-3,6,11,14-tetraazaheptadecan-1-oic acid  

نوع

  • http://www.irandoc.ac.ir/onto/irandoc-meta/Concept

مفهوم اعم

بار

  • 0

فرمول

  • C36H64N8O17

اینچی

  • InChI=1S/C36H64N8O17/c1-6-39-25-29(28(22(14-46)59-35(25)57)61-36-24(42-18(5)47)27(50)26(49)21(13-45)60-36)58-17(4)32(53)40-15(2)31(52)44-19(30(38)51)10-11-23(48)43-20(9-7-8-12-37)33(54)41-16(3)34(55)56/h15-17,19-22,24-29,35-36,39,45-46,49-50,57H,6-14,37H2,1-5H3,(H2,38,51)(H,40,53)(H,41,54)(H,42,47)(H,43,48)(H,44,52)(H,55,56)/t15-,16+,17?,19-,20-,21-,22-,24-,25-,26-,27-,28-,29-,35?,36+/m1/s1

اینچی‌کی

  • DQJCDTNMLBYVAY-ZXXIYAEKSA-N

جرم

  • 880.938

جرم تک‌ایزوتوپی

  • 880.43894

اسمایلٓ

  • [C@@H]1([C@@H]([C@H](C(O[C@@H]1CO)O)NCC)OC(C(=O)N[C@@H](C(N[C@H](CCC(N[C@@H](C(N[C@H](C(O)=O)C)=O)CCCCN)=O)C(=O)N)=O)C)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)NC(=O)C

زیرمجموعه

  • 2_STAR

مترادف مرتبط

  • Glycopeptide

در زبان های دیگر

URI

http://www.irandoc.acir/onto/irandoc/CHEBI:141615

این مفهوم را بارگیری کن:

RDF/XML TURTLE JSON-LD